Merck appointed Sakshi Yadav as Head of Process Solutions India, effective August 1, 2026, reaffirming its commitment to expanding its presence in India’s rapidly growing biopharmaceutical manufacturing sector. In her new role, Yadav will lead Merck’s Process Solutions business in India, driving strategic growth, strengthening customer engagement and supporting the development of the country’s evolving biopharmaceutical ecosystem. The appointment also reflects Merck’s continued focus on developing internal leadership talent and building future-ready management capabilities.
Sakshi Yadav to Lead Process Solutions Business
As Head of Process Solutions India, Yadav will spearhead initiatives aimed at accelerating business growth while enhancing operational excellence and customer partnerships across the Indian market. Her key responsibilities include driving strategic business expansion, strengthening customer relationships, supporting biopharmaceutical manufacturing growth, promoting operational excellence and advancing innovation across pharmaceutical production processes. Through these initiatives, Merck aims to help customers scale manufacturing operations and adopt advanced technologies for pharmaceutical development and production.
Strong Track Record of Internal Leadership
Yadav joined Merck in 2019 and has since held several leadership positions across commercial operations, the Managing Director’s Office and business excellence functions. During her tenure, she has played a significant role in leading business transformation initiatives, driving commercial growth programmes, improving operational efficiency, building high-performing cross-functional teams and strengthening organisational collaboration. According to Merck, her proven leadership capabilities and success in driving operational improvements made her a natural choice for the leadership role.
Merck Reinforces Internal Talent Development
Tony Budianto Bee, Head of Process Solutions, Asia Pacific (excluding China), Life Science business at Merck, said Yadav has consistently demonstrated the ability to deliver sustainable growth, lead organisational transformation and develop high-performing teams. He added that her appointment reflects Merck’s long-term commitment to nurturing leadership talent from within the organisation while preparing future business leaders.
Supporting India’s Growing Biopharmaceutical Industry
India’s biopharmaceutical industry continues to expand rapidly, driven by increased investments in manufacturing capacity, research and development, advanced technologies and quality systems. Against this backdrop, Merck plans to further strengthen its support for pharmaceutical manufacturers by helping customers enhance production capabilities, improve operational efficiency and accelerate innovation. Yadav will play a key role in advancing these strategic priorities while strengthening Merck’s position in one of the world’s fastest-growing life sciences markets.
Focus on Innovation and Customer Success
Sakshi Yadav said India’s biopharmaceutical sector is entering an exciting phase of growth, fuelled by innovation, manufacturing expansion and an increasing emphasis on quality and sustainability. She added that Merck remains committed to partnering with customers to strengthen manufacturing capabilities, accelerate innovation and support the continued growth of India’s biopharmaceutical industry.
Strengthening Merck’s Growth Strategy in India
The appointment of Sakshi Yadav marks another important step in Merck’s strategy to expand its Process Solutions business in India. As reported by manufactutingtodayindia.com, by combining experienced leadership with continued investments in customer support, innovation and operational excellence, the company aims to strengthen its contribution to India’s growing biopharmaceutical manufacturing ecosystem while supporting the industry’s global competitiveness.
